Phase 2 N=25 A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life
Multiple Myeloma
Primary: Overall Response Rate — 95 percentage of participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=112 Covered Metallic Stents for First-Line Treatment of Benign Bile Duct Strictures
Common Bile Duct Stricture
Primary: Early Clinical Success — 50; 41 Participants
Phase 4 N=24,081 Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Arthritis, Rheumatoid
Primary: The First Occurrence of Antiplatelet Trialists Collaboration (APTC) Composite Endpoint, Confirmed by the Clinical Events Committee (CEC). — 2.3; 2.7; 2.5; 1.7 Percentage…
N/A N=20 Sensor Off Study Using a Nellcor USB Pulse Oximetry Monitor Interface Cable
Healthy Volunteers
Primary: Report the Time Until the Device Posts "Sensor Off" After the Sensor is Removed — 98.7 Percent
N/A N=256 Community Self-help Using Thought Field Therapy in a Traumatised Population in Uganda: a Randomised Trial
Post-traumatic Stress Disorder
Primary: Change in Post-traumatic Stress Disorder Check List for Civilians (PLC-C) Score. — 32.4; 12.4; 20.6 units on a scale — p=<0.001
Phase 3 N=35 Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study
Precocious Puberty
Primary: Percentage of Children With a Stabilisation or Regression of Tanner Pubertal Stage at the End of the Study (Final Visit), Compared to Pretreatment (Month -6) and…
N/A N=72 Cognitive Training Trial
Attention Deficit Hyperactivity Disorder
Primary: Total ADHD Symptom Score From Vanderbilt ADHD Parent Rating Scale — 27.00; 26.63 units on a scale — p=.36
Phase 1 N=82 Study in Healthy Subjects to Compare the Concentrations of the Omega-3 Fatty Acids EPA and DHA in Blood When Delivered as Three New Capsules in Relation to the Epanova® Capsule Under Fasting and Fed Conditions
Relative Bioavailability · AUC · Cmax
Primary: Area Under the Plasma Concentration-time Curve From Zero to Infinity (AUC) Assessed for Eicosapentaenoic Acid (EPA) After Administration of Test Formulation 1, 2 and 3…
Phase 3 N=15,405 Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older
Herpes Zoster
Primary: Number of Subjects With Confirmed Herpes Zoster (HZ) Cases — 3; 2; 1; 6 Participants — p=<0.0001
N/A N=330 A Maintenance Program for the Be Fit Employee Wellness Program
Obesity · Overweight
Primary: Weight Loss — 3.4; 2.5 pounds — p=<0.05
Phase 2 N=80 Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer
Lung Cancer
Primary: Overall Response Rate — 65; 50 percentage of participants
Phase 3 N=612 12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients
Kidney Transplantation · Renal Transplantation
Primary: Glomular Filtration Rate (GFR) mL/Min Via Nankivell Method at Month 12 - Standard Regimen vs Certican Regimens — 62.62; 60.54; 59.47; 66.36 mL/min per 1.73m² — p=<0.0001
Phase 2 N=10 Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis
Atopic Dermatitis
Primary: IGA — 1 units on a scale
N/A N=1,229 Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap
End Stage Renal Disease (ESRD)
Primary: Positive Blood Cultures (PBCs) Per 1,000 Central Venous Catheter (CVC)-Days — 0.26; 0.59 PBCs per 1,000 CVC-days
N/A N=10 The Efficacy of Cranial Electrostimulating Therapy for Depression and Anxiety Among Homeless Adults
Depression · Anxiety
Primary: Depressive Symptoms — 13.00; 6.50 units on a scale